Monotherapy in epilepsy: role of the newer antiepileptic drugs |
| |
Authors: | Vazquez Blanca |
| |
Affiliation: | Comprehensive Epilepsy Center, Department of Neurology, NYU School of Medicine, 403 East 34th Street, New York, NY10016-4998, USA. blancavs@netscape.net |
| |
Abstract: | BACKGROUND: Monotherapy is the goal for pharmacological treatment of epilepsy. Well-controlled trials have established the efficacy of some of the newer antiepileptic drugs (AEDs) as monotherapy. OBJECTIVE: To review clinical data and expert opinions pertinent to the evaluation of most of the newer AEDs as monotherapy for epilepsy. DATA SOURCES: The MEDLINE database was searched for clinical trials using newer AEDs. Reference sections of review articles were manually searched to identify relevant studies not retrieved in MEDLINE. STUDY SELECTION: The resulting list of references was manually reviewed to identify monotherapy studies. RESULTS: Lamotrigine and oxcarbazepine demonstrated efficacy in randomized active-control trials in patients with newly diagnosed epilepsy and in substitution trials in patients refractory to conventional AEDs. CONCLUSION: Lamotrigine and oxcarbazepine are as effective as conventional AEDs at controlling partial seizures and are better tolerated. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|